Hormone therapy in the management of prostate cancer: evidence-based approaches
Leonard G. Gomella, Jaspreet Singh, Costas D. Lallas, Edouard J. Trabulsi
Abstract
Open-access reader
Leonard G. Gomella, Jaspreet Singh, Costas D. Lallas, Edouard J. Trabulsi
Abstract
Open-access reader
Hormonal therapy has been the standard for advanced prostate cancer for over 60 years. Recently, the utility of androgen ablation through various means has been demonstrated for earlier stages of disease. In particular, the strongest evidence to date involves the use of hormonal therapy in combination with radiation therapy. In this article we review the basic concepts in hormonal ablation for prostate cancer and review the evidence-based studies that support the use of hormonal therapy in early stage prostate cancer.
OpenAlex reports 42 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Hormonal therapy has been the standard for advanced prostate cancer for over 60 years. Recently, the utility of androgen ablation through various means has been demonstrated for earlier stages of disease. In particular, the strongest evidence to date involves the use of hormonal therapy in combination with radiation therapy. In this article we review the basic concepts in hormonal ablation for prostate cancer and review the evidence-based studies that support the use of hormonal therapy in early stage prostate cancer.
Key concepts: Medicine, Prostate cancer, Hormonal therapy, Management of prostate cancer, Radiation therapy, Prostate, Hormone, Hormone therapy